Prolonged Remission Induced by FENofibrate in children with newly diagnosed type 1 diabetes (PRIFEN): protocol of a randomised controlled trial.

Groele L, Dżygało K, Kowalska A, Szypowska A

Open source

DOI
10.1136/bmjopen-2023-076882
Published
2024 Feb 10
Container
BMJ open
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1136/bmjopen-2023-076882,
  title = {Prolonged Remission Induced by FENofibrate in children with newly diagnosed type 1 diabetes (PRIFEN): protocol of a randomised controlled trial.},
  author = {Groele L and Dżygało K and Kowalska A and Szypowska A},
  year = {2024},
  journal = {BMJ open},
  doi = {10.1136/bmjopen-2023-076882},
  url = {https://doi.org/10.1136/bmjopen-2023-076882}
}

RIS

TY  - JOUR
TI  - Prolonged Remission Induced by FENofibrate in children with newly diagnosed type 1 diabetes (PRIFEN): protocol of a randomised controlled trial.
AU  - Groele L
AU  - Dżygało K
AU  - Kowalska A
AU  - Szypowska A
PY  - 2024
JO  - BMJ open
DO  - 10.1136/bmjopen-2023-076882
UR  - https://doi.org/10.1136/bmjopen-2023-076882
ER  - 

APA

L, G., K, D., A, K., & A, S. (2024). Prolonged Remission Induced by FENofibrate in children with newly diagnosed type 1 diabetes (PRIFEN): protocol of a randomised controlled trial.. BMJ open. https://doi.org/10.1136/bmjopen-2023-076882

Source records